Cellsight Technologies, Inc.

This study tested a new type of PET scan that tracks immune cells in people with advanced solid tumors who are receiving checkpoint inhibitor therapy. The goal was to see if the scan could show how well the immune system is attacking the tumor. Only 9 people were enrolled before …